Study Stopped
Feasibility of subjects completing the 3 day high fat diet protocol and multiple oral glucose tests
Metabolic Adaptations to High-fat Diet
MetFlexHFD
Adaptations in Postprandial Metabolic Flexibility Following a Three-day, High-fat Diet
1 other identifier
interventional
2
1 country
1
Brief Summary
The purpose of this study is to understand how the body's response after a meal is influenced by insulin and sugar in the blood. The primary question this study seeks to address is what is the effect of reduced insulin sensitivity on postprandial metabolic flexibility to an oral glucose tolerance test. We will recruit 50 adults (ages 20-45; 50% female) who are otherwise healthy (no known clinical diagnosis) into our non-randomized crossover trial to determine the effect of changes in insulin sensitivity on metabolic response to feeding. Insulin sensitivity will be decreased using a three-day high-fat diet (HFD) with extra calories. Whole-body metabolism will be measured during a standard 75-gram oral glucose tolerance test (OGTT). Metabolic response to feeding (e.g. OGTT) will be compared before and after the HFD and compared with the control diet to understand the effect of decreased insulin sensitivity on the metabolic response to feeding. The role of biological sex as a moderator of the effect of increased insulin resistance on postprandial metabolic flexibility will also be investigated
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2024
CompletedFirst Posted
Study publicly available on registry
August 5, 2024
CompletedStudy Start
First participant enrolled
August 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedAugust 26, 2025
August 1, 2025
5 months
August 1, 2024
August 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postprandial Metabolic Flexibility
Mean difference respiratory exchange ratio during an oral glucose tolerance test following a high fat diet
3 Days
Study Arms (1)
Hypercaloric, High Fat Diet
EXPERIMENTALFor three calendar days participants will be asked to track all foods they eat and beverages they drink (habitual diet) in a mobile application. Following the three days following the habitual diet, participants will consume 165% of their estimated daily energy needs with 65% of those calories coming from fat.
Interventions
Participants will select meals from a list of sample breakfast, lunch, and dinner options from grocery stores. Typical intake will be estimated as 160-170% of resting metabolic rate, which will then be multiplied by 1.65 as the target calorie intake for the HFD. Target fat intake will be 65% of the HFD calorie target. To ensure participants will achieve the desired calorie and fat intake, they will also be provided with pre-made nutrient shakes and half-and-half. Participants will supplement their food intake with one to three shakes per day for each of the three days, depending on the fat and calorie content of the foods they select. They will be asked to add half-and-half equally between across the shakes.
Eligibility Criteria
You may qualify if:
- Males or Females between the ages of 20 and 45 years
- Body mass index (BMI) of 18.5-29.9 kg/m2
- Low risk for medical complications as determined by physical activity readiness questionnaire (PARQ).
- Low risk for food insecurity via the Hunger Vital Sign screener
You may not qualify if:
- Currently taking any antioxidant supplementation, prescription non-steroidal anti- inflammatory drugs, antibiotics, steroids, probiotics, medications for management of cholesterol, diabetes, body weight/obesity, or are undergoing transgender hormone therapy.
- Currently pregnant (verified by urine pregnancy test)
- Any history of disordered eating (i.e., anorexia nervosa, bulimia nervosa, binge eating disorder, etc.) or high risk for disordered eating via validated questionnaire (SCOFF)
- Any history of gastrointestinal diseases (i.e., gastroesophageal reflux disease, irritable bowel syndrome, Celiac disease, Crohn's disease, or lactose intolerance)
- Allergies to wheat or gluten, milk, soy, tree nuts (e.g., almonds, walnuts, pecans), or peanuts.
- Followed a ketogenic diet within the last three months
- Instructed by a medical provided to avoid a high-fat diet due to cardiovascular disease risk.
- Cardiorespiratory fitness (VO2max) greater than the 90th percentile for age and sex
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
George Washington University School of Public Health
Washington D.C., District of Columbia, 20052, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew D Barberio, PhD
George Washington University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Department of Exercise and Nutrition Science
Study Record Dates
First Submitted
August 1, 2024
First Posted
August 5, 2024
Study Start
August 12, 2024
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
August 26, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share